https://youtu.be/zrZDR4E0tKI Dosing in psychoactive drugs Dosing represents one of the three critical elements that determine the quality of a drug experience, alongside set and setting. Determining appropriate dosages can be…
Authors Steve Rolles, Anne Katrin Schlag, Fiona Measham, Lawrence Phillips, David Nutt, Daniel Bergsvik, Ole Rogeberg Published February 25, 2021 This Drug Science research was published in the International Journal…
Today’s report of over 60 deaths last year in which fentanyl was implicated raises major alarm bells in the opioid treatment community. It could be the prelude to a wave…
Authors Rosalind Gittins & Samantha Cole Published July 19, 2021 This paper describes a case report where buprenorphine was successfully used for the management of kratom (Mitragyna speciosa) dependency during…
Dr James Foulds, Consultant forensic psychiatrist, Christchurch New Zealand Methamphetamine smoking is the commonest form of stimulant use in New Zealand. Asian importation has increased recently, and the drug has…
Mephedrone is the common name for 4-methylmethcathinone. This is a synthetic derivative of cathinone, first synthesized in 1929, and largely forgotten until the early 2000s when Israeli scientists working for…
Drug Science and University College London (UCL) are pleased to announce their strategic collaboration aimed at advancing our understanding of MDMA-assisted psychotherapy. This partnership seeks to address concerns that the…
Authors Steve O’Brien and David J Nutt Published January 30, 2025 Abstract This chapter explores the complex and controversial path of MDMA-assisted therapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD)…
The use of khat (Catha edulis) has been associated with a large number of physiological and societal harms, leading to calls for it to be controlled in the UK. The…
As the khat ban approached, DrugScience commissioned a review of khat harms, following the detailed and rigorous report from the UK Government Advisory Council on the Misuse of Drugs earlier…
Click below to subscribe to the Drug Science email list to get the most up-to date research and content.
